Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Other neoplasm 1

Conditions

Neuroblastoma 8Prostatic Neoplasms 3Skin Neoplasms 2Sarcoma, Ewing 2Precancerous Conditions 2Osteosarcoma 2Neuroectodermal Tumors, Primitive 2Medulloblastoma 2Glioma 2Carcinoma, Basal Cell 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Typical Teratoid Rhabdoid Tumor 1Stomach Neoplasms 1Rhabdoid Tumor 1Osteosarcoma Recurrent 1Oligodendroglioma 1Non-melanoma Skin Cancer 1Lymphoma, Follicular 1Lung Neoplasms 1Keratosis, Actinic 1Glioblastoma 1Gastritis, Atrophic 1Esophageal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1

Interventions

HhAntag691 14Biopsy 8Imiquimod 7Aminolevulinic Acid 7sonidegib 6Tomography, Optical Coherence 6Surgical Procedures, Operative 6Photochemotherapy 6Mohs Surgery 61-phenyl-3,3-dimethyltriazene 6Radiotherapy 5Itraconazole 5Nivolumab 4Microscopy, Confocal 4Curettage 4pembrolizumab 3methyl 5-aminolevulinate 3cemiplimab 3Standard of Care 3Niacinamide 3tazarotene 2relatlimab 2X-Rays 2Watchful Waiting 2Specimen Handling 2Observation 2Magnetic Resonance Spectroscopy 2Laser Therapy 2Gene Expression Profiling 2Eflornithine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Basal Cell × Eflornithine × Clear all
NCT00005884 2019-12-13

Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer

University of Wisconsin, Madison

Phase 3 Completed
Dermatologic

Carcinoma, Basal Cell

NCT00021294 2018-09-11

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

University of Arizona

Phase 2 Completed
DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡